International Journal of Clinical Pharmacy

, Volume 40, Issue 3, pp 676–685 | Cite as

Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand

  • Amber YoungEmail author
  • June Tordoff
  • Sharon Leitch
  • Alesha Smith
Research Article


Background Providing verbal medicines information to patients may be insufficient. Providing medicine information leaflets could support verbal information, however New Zealand health professionals’ opinions or use of leaflets is unknown. Objective To examine self-reported provision and health professionals’ views about medicine information leaflets and to determine their support for tailoring patient leaflets. Setting A cross sectional survey of general practitioners (GPs) and community pharmacists in New Zealand primary care. Method GPs and pharmacists completed validated questionnaires. Data was collected using SurveyMonkey® and where applicable, Chi squared analysis was carried out. Main outcome measures Frequency of leaflet provision, how leaflets are used in practice and why, likes and dislikes of available leaflets, and opinions on providing tailored information. Results 143 GPs and 126 pharmacists responded. For new medicines, significantly more pharmacists than GPs reported providing leaflets all or most of the time. For repeat medicines, leaflets were more likely to be given only on request. Leaflets were given to ensure patients are well-informed. Most GPs and pharmacists report discussing sections of leaflets with patients. The likes and dislikes of leaflets were mostly about design and content. Both professions support tailoring leaflets to meet individual’s requirements. Conclusions Provision of medicines information needs to be re-evaluated. Relying on verbal communication is inadequate and leaflet provision appears to be suboptimal. Making leaflets more patient-centred and accessible could improve health professionals’ perceptions and use of them. Automated creation and provision of tailored summary leaflets would be beneficial. Further advantage could be gained by digital patient access.


Counselling Medicine information New Zealand Patient education Patient information leaflet Tailored information 



We gratefully acknowledge the GPs and pharmacists who participated in the study.


This research was undertaken with the aid of a PhD scholarship from the University of Otago, New Zealand.

Conflicts of interest

The authors have no conflicts of interest to declare.

Supplementary material

11096_2018_635_MOESM1_ESM.docx (18 kb)
Supplementary material 1 (DOCX 18 kb)
11096_2018_635_MOESM2_ESM.docx (16 kb)
Supplementary material 2 (DOCX 17 kb)
11096_2018_635_MOESM3_ESM.docx (28 kb)
Supplementary material 3 (DOCX 28 kb)


  1. 1.
    Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Soc Adm Pharm. 2009;5(3):197–210. Scholar
  2. 2.
    Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.CrossRefPubMedGoogle Scholar
  3. 3.
    Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–45. Scholar
  4. 4.
    Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–67.CrossRefPubMedGoogle Scholar
  5. 5.
    Medicines and Healthcare products Regulatory Agency. Always read the leaflet: getting the best information with every medicine. The Stationery Office. 2005. Accessed 15 Feb 2017.
  6. 6.
    Raynor DK, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007;15(3):209–18. Scholar
  7. 7.
    Aslani P, Hamrosi K, Feletto E. Investigating consumer medicine information (CMI) report. CMI effectiveness tender Canberra: The Pharmacy Guild of Australia and Department of Health and Ageing; 2010.Google Scholar
  8. 8.
    Sadowski CA. Providing health information to older adults. Rev Clin Gerontol. 2011;21(01):55–66.CrossRefGoogle Scholar
  9. 9.
    Speros C. More than words: Promoting health literacy in older adults. Online J Issues Nurs. 2009. Scholar
  10. 10.
    Medsafe. Guideline on the regulation of therapeutic products in New Zealand—Part 10: requirements for information for prescribers and consumers. 2013. Accessed 15 Feb 2017.
  11. 11.
    Koo M, Krass I, Aslani P. Consumer opinions on medicines information and factors affecting its use—an Australian experience. Int J Pharm Pract. 2002;10(2):107–14. Scholar
  12. 12.
    Raynor D, Blenkinsopp A, Knapp P, Grime J, Nicolson D, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–178. Scholar
  13. 13.
    Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008. Scholar
  14. 14.
    Desplenter FAM, Simoens S, Laekeman G. The impact of informing psychiatric patients about their medication: a systematic review. Pharm World Sci. 2006;28(6):329–41. Scholar
  15. 15.
    Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract. 2005;13(2):123–31. Scholar
  16. 16.
    Aslani P. Consumer medicine information conundrums. Aust Prescr. 2007;30:122–4. Scholar
  17. 17.
    Medicines and Healthcare products Regulatory Agency. Best practice guidance on the labelling and packaging of medicines. 2014. Accessed 15 Feb 2017.
  18. 18.
    Health and Consumer Directorate-General, European Commission. A guideline on the readability of the labelling and package leaflet of medicinal products for human use. Brussels 2009. Accessed 15 Feb 2017.
  19. 19.
    Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: Are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–68. Scholar
  20. 20.
    Pharmacy Council of New Zealand. Code of Ethics. 2011. Accessed 15 Feb 2017.
  21. 21.
    Health and Disability Commissioner. Code of Health and Disability Services Consumers’ Rights. 1996. Accessed 15 Feb 2017.
  22. 22.
    Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications. NZ Med J. 2002;115(1162):U183.Google Scholar
  23. 23.
    Young A, Tordoff J, Smith A. Regulatory agencies’ recommendations for medicine information leaflets: Are they in line with research findings. Res Soc Adm Pharm. 2017. Scholar
  24. 24.
    Bandesha G, Raynor DK, Teale C. Preliminary investigation of patient information leaflets as package inserts. Int J Pharm Pract. 1996;4(4):246–8.CrossRefGoogle Scholar
  25. 25.
    Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Educ Couns. 2004;53(2):167–74. Scholar
  26. 26.
    Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59. Scholar
  27. 27.
    Dickinson R, Hamrosi K, Knapp P, Aslani P, Sowter J, Krass I, et al. Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information. Int J Pharm Pract. 2013;21(4):207–15. Scholar
  28. 28.
    Young A, Tordoff J, Smith A. ‘What do patients want?’ Tailoring medicines information to meet patients’ needs. Res Soc Adm Pharm. 2016. Scholar
  29. 29.
    Puspitasari HP, Aslani P, Krass I. Pharmacists’ and consumers’ viewpoints on counselling on prescription medicines in Australian community pharmacies. Int J Pharm Pract. 2010;18(4):202–8. Scholar
  30. 30.
    Field A. Discovering statistics using IBM SPSS statistics. 4th ed. Thousand Oaks: Sage; 2013.Google Scholar
  31. 31.
    Best Practice Advocacy Centre New Zealand. bpacnz. Dunedin, New Zealand. 2017. Accessed 23 June 2017.
  32. 32.
    Javadi M, Zarea K. Understanding thematic analysis and its pitfall. J Client Care. 2016;1(1):33–9.Google Scholar
  33. 33.
    McCray AT. Promoting health literacy. J Am Med Inform Assoc. 2005;12(2):152–63.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Raynor D, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2000;264(7083):268–70.Google Scholar
  35. 35.
    Pharmacy Council of New Zealand. Code of ethics 2011. Accessed 15 Feb 2017.
  36. 36.
    Hirsh D, Clerehan R, Staples M, Osborne RH, Buchbinder R. Patient assessment of medication information leaflets and validation of the evaluative linguistic framework (ELF). Patient Educ Couns. 2009;77(2):248–54. Scholar
  37. 37.
    Medicine Information Systems (2012) Ltd. Med+info. Medicine Information Systems Ltd. Accessed 15 Feb 2017.
  38. 38.
    Canterbury District Health Board (CDHB). Healthinfo. CDHB. 2017. Accessed 15 Feb 2017.
  39. 39.
    Waitemata District Health Board (WDHB). SafeRx safe use of medicines. WDHB. 2017. Accessed 15 Feb 2017.
  40. 40.
    Paediatric Society of New Zealand (PSNZ) and the Starship Foundation. Paediatric Society of New Zealand (PSNZ) and Starship Foundation. 2017. Accessed 15 Feb 2017.
  41. 41.
    Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26(3):731–40.CrossRefGoogle Scholar
  42. 42.
    Kim HL, Hollowell CMP, Patel RV, Bales GT, Clayman RV, Gerber GS. Use of new technology in endourology and laparoscopy by American urologists: internet and postal survey. Urology. 2000;56(5):760–5. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of OtagoDunedinNew Zealand

Personalised recommendations